Please login to the form below

Not currently logged in
Email:
Password:

Financials

This page shows the latest Financials news and features for those working in and with pharma, biotech and healthcare.

NHS England to Vertex: come clean on Orkambi offer

NHS England to Vertex: come clean on Orkambi offer

appraisals. It would raise the number of CF patients receiving Vertex’drugs from 450 to 5000 this year, he asserts, and is the “largest ever financial commitment of its type in

Latest news

More from news
Approximately 75 fully matching, plus 1,032 partially matching documents found.

Latest Intelligence

  • The rise of vertical integration in the US payer landscape The rise of vertical integration in the US payer landscape

    Should the proposed acquisition be successful it would further align their strategic and financial goals, allowing CVS/Aetna to create a comprehensive consumer offering that “fills an unmet need in the

  • Mylan sees the UK paving the way for an insulin game changer Mylan sees the UK paving the way for an insulin game changer

    recognition of the financial risk of developing a biosimilar, along with its ability to save costs, is not universal.

  • 30 Women Leaders in UK Healthcare (part 2)

    She recently told the Financial Times that she regularly challenges male behaviour, no matter how trivial, including anything which will subtly but definitely exclude women from advancement, saying “it’s those

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    ICOs (formerly known as Accountable Care Systems) require exceptional individuals who can break down the many institutional, cultural and financial barriers between hospitals, primary care and local authorities.

  • Revenue down the back of the beanbag Revenue down the back of the beanbag

    This is understandable from many perspectives - the impact of the financial crisis and a broader consciousness of the lack of corporate moral responsibility. ... Graduates can get as excited about an increasing share price as any executive I have seen,

More from intelligence
Approximately 1 fully matching, plus 194 partially matching documents found.

Latest appointments

  • Industry round up: appointments Industry round up: appointments

    Rodgers, who has gained board experience in both public and private growth companies, has a background in the financial sector as a corporate financier and investment banker. ... His career history has seen him serve as interim chief financial officer

  • Healthcare comms appointments Healthcare comms appointments

    Both Ubhi and Rehman joins Lucid’s financial team and Knight becomes the group’s interim head of facilities.

  • Weekly industry appointments Weekly industry appointments

    Allen, who has also served as chief financial officer of Celltech Group, said: “I am looking forward to taking on the role of chairman and am delighted to have the opportunity

  • Novartis changes executive committee Novartis changes executive committee

    Narasimhan, said: “Robert’s deep understanding of business services coupled with his strong financial and commercial acumen make him the right person to lead NBS in the next stage of its

  • PureTech Health appoints new chief financial officer PureTech Health appoints new chief financial officer

    PureTech Health appoints new chief financial officer. Joep Muijrers joins the biopharma from Life Sciences Partners. ... Clinical-stage biopharmaceutical company PureTech Health has bolstered the team with a new chief financial officer in the form of

More from appointments
Approximately 0 fully matching, plus 211 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 104 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics